Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence01:19

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

170
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
170
Drug Regulation01:25

Drug Regulation

2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

203
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
203
Data Validation01:15

Data Validation

575
Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:
575
Data Validation01:03

Data Validation

6.3K
Data validation is an essential part of a comprehensive assessment. Validation is confirming or verifying and opening the door to gathering more assessment data as it clarifies vague or unclear data. The process of checking and verifying the collected information is called data validation. The primary purpose of data validation is to ensure data is as free from error, bias, and misinterpretation as possible.
Nursing assessment guides are generally based on holistic models rather than medical...
6.3K
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

233
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
233

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ranolazine Co-Crystal: Molecular Docking, Coformer Selection, In vitro, In vivo Pharmacokinetic Assesment in Rat Plasma.

Current topics in medicinal chemistry·2026
Same author

Synthetic Imidazole Derivatives as Multitarget Agents in Depression: Insights into Mechanism and Therapeutic Promise.

CNS & neurological disorders drug targets·2026
Same author

Neuropeptide Y Receptor Modulators in Gut Physiology and Therapy.

Current protein & peptide science·2026
Same author

Synthesis and biological evaluation of furan-1,3,4-oxadiazole as antitubercular, antibacterial, and antioxidant agents.

Future medicinal chemistry·2025
Same author

Recombinant Proteins: Evolution to their Therapeutic Potential.

Protein and peptide letters·2025
Same author

Promising Flavone Derivatives as Anticancer Agents.

Medicinal chemistry (Shariqah (United Arab Emirates))·2025

Related Experiment Video

Updated: Jan 15, 2026

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
07:00

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface

Published on: August 11, 2017

8.6K

Ensuring data integrity in the pharmaceutical lifecycle: Challenges, principles, and global implications.

Monali Rushi Dakhole1, Kalyani Ramprasad Thombre1, Krishna Radheshyam Gupta1

  • 1Department of Pharmaceutical Chemistry, Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur, India.

Annales Pharmaceutiques Francaises
|October 9, 2025
PubMed
Summary
This summary is machine-generated.

Ensuring pharmaceutical data integrity is vital for patient safety and regulatory compliance. Adhering to principles like ALCOA+ and Good Documentation Practices prevents data falsification and ensures product quality.

Keywords:
21 CFRALCOAALCOA+Data integrityGDPIntégrité des données

More Related Videos

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.4K
An Open Source Technology Platform to Manufacture Hydrogel-Based 3D Culture Models in an Automated and Standardized Fashion
08:29

An Open Source Technology Platform to Manufacture Hydrogel-Based 3D Culture Models in an Automated and Standardized Fashion

Published on: March 31, 2022

4.9K

Related Experiment Videos

Last Updated: Jan 15, 2026

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
07:00

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface

Published on: August 11, 2017

8.6K
Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.4K
An Open Source Technology Platform to Manufacture Hydrogel-Based 3D Culture Models in an Automated and Standardized Fashion
08:29

An Open Source Technology Platform to Manufacture Hydrogel-Based 3D Culture Models in an Automated and Standardized Fashion

Published on: March 31, 2022

4.9K

Area of Science:

  • Pharmaceutical Science
  • Regulatory Affairs
  • Data Management

Background:

  • Data integrity is fundamental for pharmaceutical product safety, efficacy, and quality.
  • It ensures data accuracy, consistency, and reliability throughout the product lifecycle.
  • Maintaining data integrity is crucial for regulatory adherence and patient welfare.

Purpose of the Study:

  • To explain the significance of data integrity in the pharmaceutical industry.
  • To review principles such as ALCOA+ and Good Documentation Practices (GDP).
  • To identify threats to data integrity and propose solutions for improvement.

Main Methods:

  • Literature review and analysis of data integrity principles.
  • Discussion of Good Documentation Practices (GDP).
  • Examination of threats and case studies related to data breaches.

Main Results:

  • Data integrity is essential for regulatory compliance and patient safety.
  • Threats include data falsification, poor documentation, and inadequate system controls.
  • Compromised data can lead to hazardous products and loss of public trust.

Conclusions:

  • Robust data governance and a culture of transparency are key to bolstering data integrity.
  • Implementing methodologies for data integrity ensures reliable pharmaceutical operations.
  • Adherence to regulatory standards is paramount for global pharmaceutical consistency.